Novozymes A/S (OTCMKTS:NVZMY) Share Price Passes Above Fifty Day Moving Average – Here’s What Happened

Novozymes A/S (OTCMKTS:NVZMY) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $61.13 and traded as high as $62.72. Novozymes A/S shares last traded at $62.44, with a volume of 22,274 shares.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Rothschild & Co Redburn upgraded Novozymes A/S to a “strong-buy” rating in a report on Friday, March 27th. Zacks Research upgraded shares of Novozymes A/S from a “strong sell” rating to a “hold” rating in a research note on Monday, June 8th. Finally, Kepler Capital Markets upgraded shares of Novozymes A/S from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Two analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Buy”.

Novozymes A/S Stock Performance

The company has a debt-to-equity ratio of 0.27, a current ratio of 1.67 and a quick ratio of 1.03. The company’s fifty day moving average price is $61.13 and its 200 day moving average price is $60.47. The company has a market cap of $25.88 billion, a PE ratio of 42.19, a P/E/G ratio of 2.91 and a beta of 0.92.

Novozymes A/S (OTCMKTS:NVZMY) last posted its quarterly earnings data on Tuesday, May 5th. The biotechnology company reported $0.51 EPS for the quarter, missing the consensus estimate of $0.82 by ($0.31). Novozymes A/S had a net margin of 14.22% and a return on equity of 6.52%. The firm had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. On average, equities research analysts predict that Novozymes A/S will post 2.43 earnings per share for the current year.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).